Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Portugal Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20111
20122
20131
20151
20171
20181
20191
20202
20222
20237
20245
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting8
Recruiting6
Terminated5
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Novartis Pharmaceuticals4
AstraZeneca3
Amgen2
Cephalon, Inc.2
Janssen Research & Development, LLC2
Viatris Innovation GmbH2
AbbVie1
Ablynx, a Sanofi company1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic31
Autoimmune Diseases7
Lupus Nephritis4
Connective Tissue Diseases3
Immune System Diseases3
Arthritis, Rheumatoid1
Disease1
Eye Manifestations1
Lupus Erythematosus, Cutaneous1
Lupus Erythematosus, Discoid1

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.